Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2020, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2020-05-16
DOI
10.1155/2020/5086250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease
- (2020) Morgane Linard et al. Alzheimers & Dementia
- KDS2010: A Potent Highly Selective and Reversible MAO-B Inhibitor to Abate Alzheimer’s Disease
- (2020) Abdullah Al Mamun et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Emerging Potential of Naturally Occurring Autophagy Modulator against Neurodegeneration
- (2020) Md. Ataur Rahman et al. CURRENT PHARMACEUTICAL DESIGN
- Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy
- (2020) Emily J. Koller et al. MOLECULAR NEUROBIOLOGY
- Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease
- (2020) Md. Sahab Uddin et al. CURRENT PHARMACEUTICAL DESIGN
- Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia
- (2020) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer’s Disease
- (2020) Abdullah Al Mamun et al. NEUROTOXICITY RESEARCH
- Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
- (2020) Md. Sahab Uddin et al. Oxidative Medicine and Cellular Longevity
- Circadian and sleep dysfunction in Alzheimer’s disease
- (2020) Md. Sahab Uddin et al. AGEING RESEARCH REVIEWS
- Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
- (2020) Md. Sahab Uddin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration
- (2020) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease
- (2019) Celia G. Fernandez et al. Frontiers in Aging Neuroscience
- ApoE4: an emerging therapeutic target for Alzheimer’s disease
- (2019) Mirna Safieh et al. BMC Medicine
- ApoE4 allele specific knockout using a synthetic Cas9 variant as a potential gene therapy approach for Alzheimer's disease
- (2019) R. Rabinowitz et al. CYTOTHERAPY
- Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
- (2019) Md. Farhad Hossain et al. MOLECULAR NEUROBIOLOGY
- Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
- (2019) Md. Sahab Uddin et al. Frontiers in Cell and Developmental Biology
- Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs
- (2018) Paul A. Parcon et al. Alzheimers & Dementia
- Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
- (2018) Fan Liao et al. JOURNAL OF CLINICAL INVESTIGATION
- APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
- (2018) Jonathan B. Rosenberg et al. Human Gene Therapy Clinical Development
- Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
- (2018) Alice Bittar et al. npj Vaccines
- Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder
- (2018) Rukhsana Sultana et al. JOURNAL OF ALZHEIMERS DISEASE
- The Imbalance of Vascular Molecules in Alzheimer's Disease
- (2018) Robert D. Bell JOURNAL OF ALZHEIMERS DISEASE
- Enhanced Brain Amyloid-β Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer's Disease
- (2018) Hisham Qosa et al. JOURNAL OF ALZHEIMERS DISEASE
- In Vivo and In Vitro Effects of an Apolipoprotein E Mimetic Peptide on Amyloid-β Pathology
- (2018) Shaila P. Handattu et al. JOURNAL OF ALZHEIMERS DISEASE
- Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh
- (2018) Md. Sahab Uddin et al. Psychogeriatrics
- Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
- (2018) Md. Sahab Uddin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HDL mimetic peptides affect apolipoprotein E metabolism: equal supplement or functional enhancer?
- (2018) Wenzhang Wang et al. JOURNAL OF NEUROCHEMISTRY
- Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
- (2017) Veena Theendakara et al. MOLECULAR NEUROBIOLOGY
- Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
- (2017) Tien-Phat V. Huynh et al. NEURON
- Deciphering microglial diversity in Alzheimer's disease
- (2017) Guy C. Brown et al. SCIENCE
- Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease
- (2017) Anne Urfer-Buchwalder et al. Scientific Reports
- APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
- (2017) Hélène-Marie Lanoiselée et al. PLOS MEDICINE
- Central Nervous System LipoproteinsHighlights
- (2016) Robert W. Mahley ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo
- (2016) Ishai Luz et al. Current Alzheimer Research
- Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1
- (2016) Masaya Tachibana et al. EXPERIMENTAL NEUROLOGY
- Direct Transcriptional Effects of Apolipoprotein E
- (2016) V. Theendakara et al. JOURNAL OF NEUROSCIENCE
- Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice
- (2016) S. Wattananit et al. JOURNAL OF NEUROSCIENCE
- Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
- (2016) Puneet Talwar et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
- (2015) Ramón Cacabelos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
- (2015) Rebecca Skerrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease
- (2015) B. T. Casali et al. JOURNAL OF NEUROSCIENCE
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
- (2015) Jin Hu et al. Molecular Neurodegeneration
- Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies
- (2015) Nga Bien-Ly et al. NEURON
- Treatment of Mycosis Fungoides with Bexarotene Results in Remission of Diffuse Plane Xanthomas
- (2015) Stamatis Gregoriou et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
- (2014) Eduardo Martínez-Morillo et al. ACTA NEUROPATHOLOGICA
- Genetic variants modify the effect of age onAPOEmethylation in the Genetics of Lipid Lowering Drugs and Diet Network study
- (2014) Yiyi Ma et al. AGING CELL
- APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
- (2014) Daniel M. Michaelson Alzheimers & Dementia
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
- (2014) D. Allan Butterfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo
- (2014) Moran Gilat-Frenkel et al. Current Alzheimer Research
- The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease
- (2014) Angela Hanson et al. CURRENT PHARMACEUTICAL DESIGN
- Amyloid-β Pathology andAPOEGenotype Modulate Retinoid X Receptor Agonist Activityin Vivo
- (2014) Leon M. Tai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice
- (2014) Wael Alata et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
- (2014) C. Roger White et al. JOURNAL OF LIPID RESEARCH
- Reversal of apoE4-Driven Brain Pathology and Behavioral Deficits by Bexarotene
- (2014) A. Boehm-Cagan et al. JOURNAL OF NEUROSCIENCE
- Anti-ApoE Antibody Given after Plaque Onset Decreases A Accumulation and Improves Brain Function in a Mouse Model of A Amyloidosis
- (2014) F. Liao et al. JOURNAL OF NEUROSCIENCE
- Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
- (2014) Leon M Tai et al. Molecular Neurodegeneration
- APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms
- (2014) C Conejero-Goldberg et al. MOLECULAR PSYCHIATRY
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration
- (2014) Courtney Lane-Donovan et al. NEURON
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
- (2014) Angel C. Y. Mak et al. JAMA Neurology
- Blocking the apoE/Aß interaction ameliorates Aß-related pathology in APOE ¿2 and ¿4 targeted replacement Alzheimer model mice
- (2014) Joanna E Pankiewicz et al. Acta Neuropathologica Communications
- Ten-year Experience of Bexarotene Therapy for Cutaneous T-cell Lymphoma in Finland
- (2013) L Väkevä et al. ACTA DERMATO-VENEREOLOGICA
- Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
- (2013) Magdalena A. Kuszczyk et al. AMERICAN JOURNAL OF PATHOLOGY
- Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
- (2013) Elena Kosenko et al. CNS & Neurological Disorders-Drug Targets
- Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
- (2013) Teng Jiang et al. Current Alzheimer Research
- Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased withAPOE4and Alzheimer Disease in a Transgenic Mouse Model and Human Samples
- (2013) Leon M. Tai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nucleic acid oxidation: an early feature of Alzheimer's disease
- (2013) Melissa A. Bradley-Whitman et al. JOURNAL OF NEUROCHEMISTRY
- Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
- (2013) Shan Liu et al. JOURNAL OF NEUROCHEMISTRY
- Human Apolipoprotein E4 Worsens Acute Axonal Pathology but Not Amyloid-β Immunoreactivity After Traumatic Brain Injury in 3×TG-AD Mice
- (2013) Rachel E. Bennett et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Neuronal Clearance of Amyloid- by Endocytic Receptor LRP1
- (2013) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
- (2013) Katherine D LaClair et al. Molecular Neurodegeneration
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2
- (2013) Sana Suri et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- ApoE influences amyloid- (A ) clearance despite minimal apoE/A association in physiological conditions
- (2013) P. B. Verghese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) N. F. Fitz et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) I. Tesseur et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) K. Veeraraghavalu et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) A. R. Price et al. SCIENCE
- Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
- (2013) E. Hudry et al. Science Translational Medicine
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
- (2013) Angela J. Hanson et al. JAMA Neurology
- The role of iron as a mediator of oxidative stress in Alzheimer disease
- (2012) Rudy J. Castellani et al. BIOFACTORS
- U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma
- (2012) J.J. Scarisbrick et al. BRITISH JOURNAL OF DERMATOLOGY
- ApolipoproteinE mimetic peptides improve outcome after focal ischemia
- (2012) Haichen Wang et al. EXPERIMENTAL NEUROLOGY
- APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
- (2012) Katherine L. Youmans et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
- (2012) Jungsu Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Small-Molecule Structure Correctors Target Abnormal Protein Structure and Function: Structure Corrector Rescue of Apolipoprotein E4–Associated Neuropathology
- (2012) Robert W. Mahley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent A Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
- (2012) N. Bien-Ly et al. JOURNAL OF NEUROSCIENCE
- Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n= 669): A Pilot Assay for Methionine-containing Proteotypic Peptides
- (2012) Romain Simon et al. MOLECULAR & CELLULAR PROTEOMICS
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimers Disease Transgenics
- (2012) M.P. Vitek et al. Neurodegenerative Diseases
- The Apolipoprotein-E-Mimetic COG112 Protects Amyloid Precursor Protein Intracellular Domain-Overexpressing Animals from Alzheimer's Disease-Like Pathological Features
- (2012) Kaushik Ghosal et al. Neurodegenerative Diseases
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
- (2012) Xianglan Yao et al. Frontiers in Pharmacology
- Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
- (2011) Neha Mehta et al. Clinical Lymphoma Myeloma & Leukemia
- Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
- (2011) Jens Brodbeck et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid- Amyloidosis
- (2011) J. Kim et al. JOURNAL OF NEUROSCIENCE
- Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid- Uptake
- (2011) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid- (A ) and acts in concert with A to elicit neuronal and behavioral deficits in mice
- (2011) N. Bien-Ly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The vascular contribution to Alzheimer's disease
- (2010) Robin Altman et al. CLINICAL SCIENCE
- Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease
- (2010) Hung-Kai Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
- (2010) James J. Donkin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
- (2010) Mitsuru Shinohara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuronal LRP1 Knockout in Adult Mice Leads to Impaired Brain Lipid Metabolism and Progressive, Age-Dependent Synapse Loss and Neurodegeneration
- (2010) Q. Liu et al. JOURNAL OF NEUROSCIENCE
- Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
- (2010) Daniel T. Laskowitz et al. JOURNAL OF NEUROTRAUMA
- ApoE mimetic peptide decreases Aβ production in vitro and in vivo
- (2010) S Sakura Minami et al. Molecular Neurodegeneration
- Aβ20–29 peptide blocking apoE/Aβ interaction reduces full-length Aβ42/40 fibril formation and cytotoxicity in vitro
- (2010) Jian Hao et al. NEUROPEPTIDES
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents
- (2010) David O. Osei-Hwedieh et al. PHARMACOLOGY & THERAPEUTICS
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
- (2010) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apolipoprotein E: From lipid transport to neurobiology
- (2010) Paul S. Hauser et al. PROGRESS IN LIPID RESEARCH
- Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway
- (2009) Maaike Kockx et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- Liver X receptor activation restores memory in aged AD mice without reducing amyloid
- (2009) Tim Vanmierlo et al. NEUROBIOLOGY OF AGING
- Isoform-specific proteolysis of apolipoprotein-E in the brain
- (2009) David A. Elliott et al. NEUROBIOLOGY OF AGING
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
- (2009) Jungsu Kim et al. NEURON
- Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice
- (2008) Ning Zhong et al. Alzheimers & Dementia
- APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway
- (2008) Sigrid B Sando et al. BMC Neurology
- Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
- (2008) Suzanne E. Wahrle et al. JOURNAL OF CLINICAL INVESTIGATION
- Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
- (2008) Robert W. Mahley et al. JOURNAL OF LIPID RESEARCH
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
- Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
- (2008) Domenico Praticò TRENDS IN PHARMACOLOGICAL SCIENCES
- Oxidatively modified RNA in mild cognitive impairment
- (2007) Mark A. Lovell et al. NEUROBIOLOGY OF DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More